Li et al. recently found that protein tyrosine phosphatase non-receptor type 2 (PTPN2) could attenuate renal injury and fibrosis by suppressing STAT1/3-induced inflammation in early DN [135]. The gene discussed is STAT1; the disease is liver dysplastic nodule.